Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2023-06-20 | 2023-07-06 | 195815 |
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2023-11-03 | 2024-01-19 | 209145 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2022-05-19 | 2022-06-09 | 160994 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2022-08-18 | 2023-07-05 | 167156 |
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2022-08-18 | 2023-10-06 | 167197 |
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2020-03-06 | 2020-03-19 | 107964 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2020-04-02 | 2020-06-04 | 110679 |
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Actual shortage | 2024-08-08 | 2025-04-24 | 234891 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2021-03-11 | 2021-04-15 | 135558 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2021-04-29 | 2021-08-07 | 138291 |
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2021-06-03 | 2021-10-14 | 140390 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-05-20 | 2021-06-03 | 139725 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140363 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167203 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176824 |
| TEVA-BUPRENORPHINE/NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144704 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2024-03-07 | 2024-06-27 | 221534 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2024-03-07 | 2024-06-27 | 221537 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215743 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215746 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
| RATIO-LENOLTEC NO 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231583 |
| TEVA-ACYCLOVIR | 800MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256128 |
| TEVA-ACYCLOVIR | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256122 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256125 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126903 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126900 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152351 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-09-24 | 2020-09-24 | 124896 |